1 North Wealth Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.13M Sell
3,403
-548
-14% -$556K 1.13% 29
2025
Q4
$4.25M Buy
3,951
+2
+0.1% +$1.91K 1.49% 25
2025
Q3
$3.01M Buy
3,949
+5
+0.1% +$3.72K 1.23% 27
2025
Q2
$3.07M Buy
3,944
+70
+2% +$54.4K 1.22% 26
2025
Q1
$3.2M Sell
3,874
-181
-4% -$151K 1.48% 22
2024
Q4
$3.13M Buy
+4,055
New +$3.36M 1.33% 26
2019
Q4
$834K Buy
6,349
+55
+0.9% +$6.38K 0.52% 46
2019
Q3
$704K Buy
+6,294
New +$701K 0.47% 47
2019
Q1
$820K Sell
6,316
-2,478
-28% -$301K 0.58% 43
2018
Q4
$1.02M Buy
+8,794
New +$982K 0.85% 35

Other funds holding LLY

1 North Wealth Services's LLY Position: Q1 2026 in Review

1 North Wealth Services reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $556K and leaving 3,403 shares worth $3.13M. The position accounts for 1.13% of the portfolio, ranked #29.

1 North Wealth Services first reported a position in LLY in Q4 2018 and has held it in 10 quarters since. The position peaked at $4.25M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • 1 North Wealth Services held 3,403 shares of Eli Lilly worth $3.13M as of Q1 2026.
  • 1 North Wealth Services sold 548 Eli Lilly shares in Q1 2026, an estimated $556K.
  • Eli Lilly made up 1.13% of 1 North Wealth Services's portfolio in Q1 2026, its #29 holding.
  • 1 North Wealth Services first reported a position in Eli Lilly in Q4 2018 and has held it in 10 quarters since.
  • 1 North Wealth Services's Eli Lilly position peaked at $4.25M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 1 North Wealth Services's 13F filing for Q1 2026, filed 4 May 2026.